Press release
Adrenocortical Hormones Api Market 2024: Industry Growth and Future Scope Forecast - Sanofi, Pfizer CentreOne, GlaxoSmithKline, Symbiotec Pharmalab
Adrenocortical Hormones Api Market Research Report By DataM Intelligence: A comprehensive analysis of current and emerging trends provides clarity on the dynamics of the Adrenocortical Hormones Api market. The report employs Porter's Five Forces model to assess key factors such as the influence of suppliers and customers, risks posed by different entities, competitive intensity, and the potential of emerging entrepreneurs, offering valuable insights. Additionally, the report presents research data from various companies, including their benefits, gross margins, and strategic decisions in the global market, all conveyed through tables, charts, and infographics.Download Free Sample PDF: https://datamintelligence.com/download-sample/adrenocortical-hormones-api-market
What is the projected growth rate (CAGR) of the Global Adrenocortical Hormones Api market from 2024 to 2031, and what is the market value expected to change by 2031?
The Global Adrenocortical Hormones API Market Expected to reach at a high CAGR By 2031
What is Adrenocortical Hormones Api Market?
Adrenocortical hormones are steroid hormones produced by the adrenal cortex, the outer layer of the adrenal glands located on top of each kidney. These hormones play crucial roles in regulating various physiological processes in the body, including metabolism, immune response, and stress adaptation.
Growth Driver
The Use of Adrenocortical Hormones in Various Treatments
The demand for adrenocortical hormones in the active pharmaceutical ingredient (API) market is driven by several factors. One notable application is the use of adrenocorticotropic hormone (ACTH) therapy for children with intractable seizures who do not respond to standard antiepileptic medications. However, further research is needed to assess the long-term effectiveness of ACTH in managing these complex cases.
Key Players:
Profiles of some of the major players in the global Adrenocortical Hormones Api market, which include:
Sanofi, Pfizer CentreOne, GlaxoSmithKline, Symbiotec Pharmalab, Sun Pharmaceutical, Cipla, Hovione, Teva Pharmaceuticals Pvt Ltd, Tianjin Pharmaceutical Group Co. Ltd, Great Pacific Exports.
Industry Development:
On January 11, 2023, AstraZeneca announced the launch of Airsupra (albuterol/budesonide), previously known as PT027. This medication has been approved in the United States for the as-needed treatment and prevention of bronchoconstriction, as well as for reducing the risk of exacerbations in individuals with asthma aged 18 and older.
On August 3, 2021, Sanofi finalized a definitive agreement to acquire all outstanding shares of Translate Bio for $38.00 per share in cash, totaling approximately $3.2 billion in equity value. This acquisition is part of Sanofi's strategy to enhance the application of messenger RNA (mRNA) technology for developing therapeutics and vaccines. The deal received approval from the boards of directors of both Sanofi and Translate Bio.
On March 31, 2021, Piramal Pharma Solutions (PPS) announced its intention to acquire API manufacturer Hemmo Pharmaceuticals for ₹775 crore. This acquisition will allow PPS to expand its operations to include the development and production of peptide active pharmaceutical ingredients (APIs). Hemmo Pharmaceuticals is recognized as one of the few global companies dedicated exclusively to the manufacture of synthetic peptide APIs.
The purpose of the report is to offer a comprehensive analysis of the market, along with insightful conclusions, statistical data, historical information, market data that has been confirmed by the industry, and predictions based on a sound methodology. By identifying and examining market segments and forecasting global market size, the study also contributes to understanding the dynamics and structure of the global Adrenocortical Hormones Api market.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=adrenocortical-hormones-api-market
Market Segments:
The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviours.
By Type: Glucocorticoid, Betamethasone, Hydrocortisone, Mineralocorticoids, Fludrocortisone, Others
By Route of Administration: Injectable Drugs, Oral Drugs, For External Use Drugs, Inhalation Drugs
Regional Break out:
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/adrenocortical-hormones-api-market
Key Features
➧ Gain deep insights into market dynamics, trends, and opportunities to stay ahead in a competitive landscape.
➧ Track competitor's movements in real time, allowing you to swiftly adapt strategies and remain competitive.
➧ Compare your performance with industry leaders to identify gaps, strengths, and areas for improvement.
➧ Stay updated with emerging market trends, technological advancements, and customer behaviour to refine your strategy.
➧ Receive actionable insights and recommendations to drive your business toward growth and long-term success.
➧ Tailor competitive intelligence to your unique business needs, ensuring relevant and focused analysis.
➧ Evaluate supply chain efficiency and logistics strategies to optimize operations and minimize disruptions.
➧ Understand key players, stakeholders, and partnerships to navigate the competitive landscape more effectively.
➧ Identify and target specific market segments with detailed intelligence on customer preferences and behaviours.
➧ Stay informed on regulatory changes and legal requirements impacting your industry to ensure compliance and mitigate risks.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adrenocortical Hormones Api Market 2024: Industry Growth and Future Scope Forecast - Sanofi, Pfizer CentreOne, GlaxoSmithKline, Symbiotec Pharmalab here
News-ID: 3702000 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Restaurant POS Software Market to Reach US$ 14.76 Billion by 2033 at 12.6% CAGR …
Restaurant POS Software Market reached US$ 5.15 billion in 2024 and is expected to reach US$ 14.76 billion by 2033, growing at a CAGR of 12.6% during the forecast period of 2025 to 2033.
The market is experiencing robust growth as increasing demand for efficient, integrated, and cloud-based point-of-sale solutions drives adoption across restaurants, cafes, quick service outlets, and hospitality chains. Restaurant POS software enhances order management, payment processing, inventory tracking,…
Natural Gas Storage Market Trends: Strategic Insights for Energy Companies and I …
DataM Intelligence released its latest game-changing report "Natural Gas Storage Market Size 2025" Packed with actionable insights for decision-makers, this report goes beyond numbers to decode regional growth hotspots, high-potential market segments, CAGR forecasts, revenue performance of leading players, and the real drivers steering the industry forward. Whether you're an investor, manufacturer, distributor, or technology strategist, this report delivers a crystal-clear, telescopic outlook on market size (value & volume), Growth…
Mobile Threat Defence Market to Reach US$ 12.85 Billion by 2033 at 13.5% CAGR | …
Mobile Threat Defence Market reached US$ 4.12 billion in 2024 and is expected to reach US$ 12.85 billion by 2033, growing at a CAGR of 13.5% during the forecast period of 2025 to 2033.
The market is gaining strong momentum as rising adoption of mobile devices, increasing occurrence of sophisticated cyberattacks, and growing enterprise focus on securing mobile endpoints drive demand for advanced threat defence solutions. Mobile threat defence (MTD) technologies…
Identity and Access Management Market Set for Explosive Growth to US$ 54.04 Bill …
The Global Identity and Access Management Market was US$18,602.14 million in 2024 and is expected to reach US$54,038.25 million in 2032, growing at a CAGR of 14.4% during the forecast period (2025-2032).
Market growth is driven by escalating cybersecurity threats, rising adoption of cloud and hybrid IT environments, and stringent regulatory compliance needs like GDPR and CCPA. Advancements in AI-powered authentication, zero-trust architectures, and the surge in remote work are further…
More Releases for Adrenocortical
Adrenocortical Carcinoma Treatment Market Diagnostic Improvements and Evolving T …
The Adrenocortical Carcinoma (ACC) Treatment Market is growing steadily as improvements in diagnostic imaging, surgical oncology, and targeted therapies enhance the management of this rare but aggressive endocrine malignancy. ACC often presents late and requires multimodal treatment including surgery, adrenalectomy, mitotane therapy, chemotherapy, and emerging immunotherapies. Rising clinical awareness, improved diagnostic accuracy, and expansion of cancer centers specializing in rare tumors are fueling demand for effective ACC treatments.
Download Full PDF…
Adrenocortical Hormones API Market Size to Expand Lucratively by 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Adrenocortical Hormones API Market - (By Type (Dexamethasone Series, Betamethasone Series, Hydrocortisone Series & Others), By Application (Injectable Drugs, Oral Drugs, For External Use Drugs, Inhalation Drugs)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Adrenocortical Hormones API Market is valued at US$ 2.24 Billion…
Adrenocortical Carcinoma Drugs Market Overview: Growth, Share, Value, Size, and …
The global Adrenocortical Carcinoma Drugs market is projected to reach approximately USD 0.85 billion by 2033, growing at a compound annual growth rate (CAGR) of around 7.2% from 2025 to 2033.
Adrenocortical Carcinoma Drugs Market Overview
The global Adrenocortical Carcinoma (ACC) drugs market is experiencing growth, driven by the increasing incidence of this rare endocrine malignancy and advancements in therapeutic approaches. ACC is characterized by aggressive tumor behavior and limited treatment options,…
Adrenocortical Hormones API Market Survey Detailed Analysis and Forecast 2024-20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Adrenocortical Hormones API Market - (By Type (Dexamethasone Series, Betamethasone Series, Hydrocortisone Series & Others), By Application (Injectable Drugs, Oral Drugs, For External Use Drugs, Inhalation Drugs)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Adrenocortical Hormones API Market is valued at US$ 2.24 Billion…
Adrenocortical Carcinoma Treatment: Challenges, Advances, and Market Dynamics
Adrenocortical carcinoma (ACC) is a rare and aggressive form of cancer originating in the adrenal cortex, the outer layer of the adrenal glands. These glands, located above the kidneys, are responsible for producing hormones that regulate a variety of bodily functions, such as metabolism, blood pressure, and immune response. ACC is often diagnosed at an advanced stage due to its asymptomatic early course, and treatment options are limited. In this…
Adrenocortical Hormones API Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Adrenocortical Hormones API market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Adrenocortical Hormones APImarket by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Adrenocortical Hormones APImarket, market definition, overview, industry opportunities…
